2007

Motac Cognition completes a second round of expansion and now offers a wide range of model platforms for assessing cognitive performance relevant to Parkinson’s disease, Alzheimer’s disease, schizophrenia and ADHD.

2008
Motac Cognition takes occupancy of new, stand-alone research facility.